WCN26-4193 Persistent Increased Risk of Renal Replacement Therapy Following COVID-19: A Two-Year Follow-Up Study in Japan using propensity score matching and inverse probability censoring weighting

Read full text Summarise with VIRAT
Authors: Daisuke Miyamori, Shingo Fukuma, Shuhei Yoshida, Daisuke Haratake, Kotaro Ikeda, Masanori Ito
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Although COVID-19 has been associated with multi-organ complications, growing evidence from Western populations suggests an increased risk of chronic kidney disease progression and end-stage renal disease (ESRD) following infection. However, data from Asian populations remain insufficiently characterized despite potential differences in comorbidity profiles and healthcare systems. Given the profound burden of ESRD on patients, families, and healthcare systems, elucidating whether COVID-19 increases this risk in the Asian context is of major clinical and public health importance.

Fields of Study & Subjects

COVID-19 Clinical Research Studies Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104332–104332
Publication date
25 March 2026
Language
EN